{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:18:51Z","timestamp":1741238331716,"version":"3.38.0"},"reference-count":9,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.nephro.2007.02.004","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:17:16Z","timestamp":1175944636000},"page":"65-68","source":"Crossref","is-referenced-by-count":0,"title":["R\u00e9mission prolong\u00e9e induite par\u00a0le\u00a0rituximab d'une r\u00e9cidive de\u00a0glom\u00e9rulon\u00e9phrite extramembraneuse"],"prefix":"10.1684","volume":"3","author":[{"given":"Hugo","family":"W\u00e9clawiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2007.02.004_bib1","first-page":"67","article-title":"Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes","volume":"31","author":"Wehrrmann","year":"1989","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.nephro.2007.02.004_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00007890-199505150-00009","article-title":"Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients","volume":"59","author":"Couchoud","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2007.02.004_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00007890-199909150-00007","article-title":"Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR)","volume":"68","author":"Hariharan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2007.02.004_bib4","first-page":"144","article-title":"Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors","volume":"50","author":"Cosyns","year":"1998","journal-title":"Clin. Nephrol."},{"issue":"12","key":"10.1016\/j.nephro.2007.02.004_bib5","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/j.1600-6143.2006.01544.x","article-title":"Anti-CD20 Monoclonal Antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient","volume":"6","author":"Gallon","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.nephro.2007.02.004_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2007.02.004_bib7","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","article-title":"Rituximab in idiopathic membranous nephropathy: a one-year prospective study","volume":"14","author":"Ruggenenti","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.nephro.2007.02.004_bib8","first-page":"328","article-title":"CD20-positive infiltrates in human membranous glomerulonephritis","volume":"18","author":"Cohen","year":"2005","journal-title":"J. Nephrol."},{"key":"10.1016\/j.nephro.2007.02.004_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5414\/CNP66054","article-title":"Successful therapeutic use of rituximab in refractory membranous glomerulonephritis","volume":"66","author":"Cobo","year":"2006","journal-title":"Clin. Nephrol."}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725507000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725507000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2007.02.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:50:59Z","timestamp":1741182659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725507000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1769725507000417"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2007.02.004","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}